These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29155322)

  • 21. Colonisation with multi-resistant Enterobacteriaceae in hospitalised Danish patients with a history of recent travel: a cross-sectional study.
    Lausch KR; Fuursted K; Larsen CS; Storgaard M
    Travel Med Infect Dis; 2013; 11(5):320-3. PubMed ID: 23810306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum β-lactamases and carbapenemases).
    Lynch JP; Clark NM; Zhanel GG
    Expert Opin Pharmacother; 2013 Feb; 14(2):199-210. PubMed ID: 23321047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for KPC-producing Enterobacteriaceae acquisition and infection in a healthcare setting with possible local transmission: a case-control study.
    Cronin KM; Poy Lorenzo YS; Olenski ME; Bloch AE; Visvanathan K; Waters MJ; Buising KL
    J Hosp Infect; 2017 Jun; 96(2):111-115. PubMed ID: 28389093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical significance and risk factors for multidrug resistant Enterobacteriaceae colonization].
    Padilla-Serrano A; Serrano-Castañeda JJ; Carranza-González R; García-Bonillo MP
    Rev Esp Quimioter; 2018 Jun; 31(3):257-262. PubMed ID: 29726670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a prediction model for the acquisition of extended spectrum beta-lactam-resistant organisms in U.S. international travellers.
    Brown DG; Worby CJ; Pender MA; Brintz BJ; Ryan ET; Sridhar S; Oliver E; Harris JB; Turbett SE; Rao SR; Earl AM; LaRocque RC; Leung DT
    J Travel Med; 2023 Oct; 30(6):. PubMed ID: 36864572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae.
    Kantele A; Lääveri T; Mero S; Vilkman K; Pakkanen SH; Ollgren J; Antikainen J; Kirveskari J
    Clin Infect Dis; 2015 Mar; 60(6):837-46. PubMed ID: 25613287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended-spectrum beta-lactamases in urinary tract infections caused by Enterobacteria: understanding and guidelines for action.
    García-Tello A; Gimbernat H; Redondo C; Arana DM; Cacho J; Angulo JC
    Actas Urol Esp; 2014 Dec; 38(10):678-84. PubMed ID: 24984581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary tract infection caused by fluoroquinolone- and cephem-resistant Enterobacteriaceae.
    Muratani T; Matsumoto T
    Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S10-3. PubMed ID: 16829056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High burden of extended-spectrum β-lactamase-producing Enterobacteriaceae in Gabon.
    Schaumburg F; Alabi A; Kokou C; Grobusch MP; Köck R; Kaba H; Becker K; Adegnika AA; Kremsner PG; Peters G; Mellmann A
    J Antimicrob Chemother; 2013 Sep; 68(9):2140-3. PubMed ID: 23645586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidrug-resistant ESBL-producing Enterobacteriaceae and associated risk factors in community infants in Lebanon.
    Hijazi SM; Fawzi MA; Ali FM; Abd El Galil KH
    J Infect Dev Ctries; 2016 Sep; 10(9):947-955. PubMed ID: 27694727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of antimicrobial agents for treatment and prevention of travellers' diarrhoea in the face of enhanced risk of transient fecal carriage of multi-drug resistant enterobacteriaceae: setting the stage for consensus recommendations.
    DuPont HL; Steffen R
    J Travel Med; 2017 Apr; 24(suppl_1):S57-S62. PubMed ID: 28881862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England.
    Potz NA; Hope R; Warner M; Johnson AP; Livermore DM;
    J Antimicrob Chemother; 2006 Aug; 58(2):320-6. PubMed ID: 16735428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The intestinal microbiota predisposes to traveler's diarrhea and to the carriage of multidrug-resistant Enterobacteriaceae after traveling to tropical regions.
    Leo S; Lazarevic V; Gaïa N; Estellat C; Girard M; Matheron S; Armand-Lefèvre L; Andremont A; Schrenzel J; Ruppé E
    Gut Microbes; 2019; 10(5):631-641. PubMed ID: 30714464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology and risk factors for faecal extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) carriage derived from residents of seven nursing homes in western Shanghai, China.
    Zhao SY; Zhang J; Zhang YL; Wang YC; Xiao SZ; Gu FF; Guo XK; Ni YX; Han LZ
    Epidemiol Infect; 2016 Mar; 144(4):695-702. PubMed ID: 26260355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methicillin-resistant staphylococci (MRS) and extended-spectrum beta-lactamases (ESBL)-producing Enterobacteriaceae in companion animals: nosocomial infections as one reason for the rising prevalence of these potential zoonotic pathogens in clinical samples.
    Wieler LH; Ewers C; Guenther S; Walther B; Lübke-Becker A
    Int J Med Microbiol; 2011 Dec; 301(8):635-41. PubMed ID: 22000738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended-Spectrum beta (β)-Lactamases and Antibiogram in Enterobacteriaceae from Clinical and Drinking Water Sources from Bahir Dar City, Ethiopia.
    Abera B; Kibret M; Mulu W
    PLoS One; 2016; 11(11):e0166519. PubMed ID: 27846254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for colonization with extended-spectrum beta-lactamase producing Enterobacteriaceae in healthcare students on clinical assignment abroad: A prospective study.
    Angelin M; Forsell J; Granlund M; Evengård B; Palmgren H; Johansson A
    Travel Med Infect Dis; 2015; 13(3):223-9. PubMed ID: 25982453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting Antibiotic Resistance in Urinary Tract Infection Patients with Prior Urine Cultures.
    Dickstein Y; Geffen Y; Andreassen S; Leibovici L; Paul M
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4717-21. PubMed ID: 27216064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.
    Ben-Ami R; Rodríguez-Baño J; Arslan H; Pitout JD; Quentin C; Calbo ES; Azap OK; Arpin C; Pascual A; Livermore DM; Garau J; Carmeli Y
    Clin Infect Dis; 2009 Sep; 49(5):682-90. PubMed ID: 19622043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vital Signs: Containment of Novel Multidrug-Resistant Organisms and Resistance Mechanisms - United States, 2006-2017.
    Woodworth KR; Walters MS; Weiner LM; Edwards J; Brown AC; Huang JY; Malik S; Slayton RB; Paul P; Capers C; Kainer MA; Wilde N; Shugart A; Mahon G; Kallen AJ; Patel J; McDonald LC; Srinivasan A; Craig M; Cardo DM
    MMWR Morb Mortal Wkly Rep; 2018 Apr; 67(13):396-401. PubMed ID: 29621209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.